Brief Reports
Copyright ©The Author(s) 2003.
World J Gastroenterol. May 15, 2003; 9(5): 1126-1128
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.1126
Table 1 Characteristics of the patients in diabetic and control groups
DiabeticsControlP
n (F/M)40 (21/19)63 (25/40)> 0.05
Age (y)56 ± 754 ± 9> 0.05
Diabetes duration (y)7.2 ± 5-
HbA1c (%)7.4 ± 1.3-
Table 2 Prevalence of gastrointestinal symptoms in type 2 diabetic patients before and after the treatment
Before (%)After (%)P
Epigastric pain75 (30/40)30 (12/40)< 0.05
Bloating68 (27/40)43 (17/40)NS
Pyrosis63 (25/40)38 (15/40)NS
Nausea55 (22/40)23 (9/40)< 0.05
Belching63 (25/40)30 (12/40)< 0.05
Early satiety30 (12/40)20 (8/40)NS
Table 3 Comparison of demographic data of diabetic patients in whom Hp was eradicated and Hp was not eradicated
Hp (+) at control endoscopyHp (-) at control endoscopyP
Female sex (%)5347> 0.05
Age (y)56.2 ± 855.8 ± 8> 0.05
Diabetes duration (y)7.3 ± 57.2 ± 5> 0.05
HbA1c (%)7.2 ± 1.27.2 ± 1.2> 0.05